(RTTNews) - Swiss biopharmaceutical company Ascendis Pharma A/S (ASND) announced Monday that the U.S. Food & Drug Administration (FDA) has approved SKYTROFA (lonapegsomatropin-tcgd; developed as ...
Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...
Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled A ...
Growth hormone, produced by the pituitary gland, plays a critical role in cell regeneration, growth, and maintaining healthy body tissue, including the brain and vital organs. While synthetic human ...
Please provide your email address to receive an email when new articles are posted on . In a phase 3 trial, lonapegsomatropin was associated with more fat loss in the trunk than placebo. Body ...
MISSISSAUGA, ON, Oct. 15, 2025 /CNW/ - Novo Nordisk has announced that Sogroya ® (somapacitan injection) is now commercially available in Canada. Sogroya ® is indicated for the long-term treatment of ...
Children with growth hormone deficiency (GHD) have differences in gut microbiota and microbial metabolites from both individuals with idiopathic short stature (ISS) and healthy controls, suggesting an ...
Recent research findings put a spotlight on the link between human growth hormone (HGH) and Alzheimer’s disease. Could taking HGH increase your risk of Alzheimer’s? Ultimately, scientists say they ...
MRI radiomics model uses pituitary scans to accurately predict growth hormone deficiency in children, providing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback